Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Gains from Investment Securities (2016 - 2025)

MedWellAI (MWAI) has disclosed Gains from Investment Securities for 9 consecutive years, with $510634.0 as the latest value for Q2 2023.

  • On a quarterly basis, Gains from Investment Securities rose 242.21% to $510634.0 in Q2 2023 year-over-year; TTM through Mar 2024 was $510634.0, a 158.71% increase, with the full-year FY2022 number at -$46999.0, down 104.81% from a year prior.
  • Gains from Investment Securities was $510634.0 for Q2 2023 at MedWellAI, up from -$510634.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $717073.0 in Q3 2021 to a low of -$510634.0 in Q1 2023.
  • A 5-year average of -$13650.5 and a median of -$1060.0 in 2019 define the central range for Gains from Investment Securities.
  • Biggest YoY gain for Gains from Investment Securities was 9872.24% in 2021; the steepest drop was 4012.8% in 2021.
  • MedWellAI's Gains from Investment Securities stood at -$2235.0 in 2019, then tumbled by 9174.32% to -$207281.0 in 2020, then soared by 445.94% to $717073.0 in 2021, then tumbled by 93.49% to $46715.0 in 2022, then skyrocketed by 993.08% to $510634.0 in 2023.
  • Per Business Quant, the three most recent readings for MWAI's Gains from Investment Securities are $510634.0 (Q2 2023), -$510634.0 (Q1 2023), and $46715.0 (Q4 2022).